JP2016503434A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016503434A5 JP2016503434A5 JP2015545618A JP2015545618A JP2016503434A5 JP 2016503434 A5 JP2016503434 A5 JP 2016503434A5 JP 2015545618 A JP2015545618 A JP 2015545618A JP 2015545618 A JP2015545618 A JP 2015545618A JP 2016503434 A5 JP2016503434 A5 JP 2016503434A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- fusion protein
- nucleic acid
- acid molecule
- cytokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2012/001629 WO2014085947A1 (zh) | 2012-12-05 | 2012-12-05 | 趋化素-细胞素融合蛋白和其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016503434A JP2016503434A (ja) | 2016-02-04 |
| JP2016503434A5 true JP2016503434A5 (enExample) | 2017-03-30 |
| JP6174710B2 JP6174710B2 (ja) | 2017-08-02 |
Family
ID=50882722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015545618A Active JP6174710B2 (ja) | 2012-12-05 | 2012-12-05 | ケモカイン−サイトカイン融合タンパク質およびその利用 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US20150307577A1 (enExample) |
| EP (1) | EP2930189B1 (enExample) |
| JP (1) | JP6174710B2 (enExample) |
| CN (1) | CN104968686B (enExample) |
| AU (1) | AU2012396113B2 (enExample) |
| CA (1) | CA2893981C (enExample) |
| WO (1) | WO2014085947A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7165717B2 (ja) | 2017-03-15 | 2022-11-04 | パンディオン・オペレーションズ・インコーポレイテッド | 標的免疫寛容 |
| MX2019013517A (es) | 2017-05-24 | 2020-08-17 | Pandion Operations Inc | Inmunotolerancia dirigida. |
| US10174091B1 (en) | 2017-12-06 | 2019-01-08 | Pandion Therapeutics, Inc. | IL-2 muteins |
| USRE50550E1 (en) | 2017-12-06 | 2025-08-26 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| US10946068B2 (en) | 2017-12-06 | 2021-03-16 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| EP3972992A4 (en) | 2019-05-20 | 2023-07-19 | Pandion Operations, Inc. | MADCAM TARGETED IMMUNOTLERANCE |
| WO2021168079A1 (en) | 2020-02-21 | 2021-08-26 | Pandion Operations, Inc. | Tissue targeted immunotolerance with a cd39 effector |
| TW202309270A (zh) * | 2021-04-19 | 2023-03-01 | 美商步行魚醫療公司 | 用於細胞療法的ｂ細胞擴增之方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU778611B2 (en) * | 1999-08-09 | 2004-12-16 | Merck Patent Gmbh | Multiple cytokine-antibody complexes |
| CA2322687A1 (en) * | 1999-10-29 | 2001-04-29 | Regents Of The University Of California | Compositions containing c-terminal polypeptides of angiogenic chemokines and methods of use |
| WO2001040311A1 (fr) * | 1999-11-30 | 2001-06-07 | Shionogi & Co., Ltd. | Proteine fusionnee de chimiokine slc-il2 |
| US20050053579A1 (en) * | 2001-10-23 | 2005-03-10 | Jacques Galipeau | Novel synthetic chimeric fusion transgene with immuno-therapeutic uses |
| US20050287118A1 (en) * | 2003-11-26 | 2005-12-29 | Epitomics, Inc. | Bacterial plasmid with immunological adjuvant function and uses thereof |
| CN101445560A (zh) * | 2008-12-31 | 2009-06-03 | 河南省生物工程技术研究中心 | 一种畜禽用融合蛋白的制备方法 |
-
2012
- 2012-12-05 CA CA2893981A patent/CA2893981C/en active Active
- 2012-12-05 CN CN201280077622.3A patent/CN104968686B/zh active Active
- 2012-12-05 US US14/649,714 patent/US20150307577A1/en not_active Abandoned
- 2012-12-05 AU AU2012396113A patent/AU2012396113B2/en active Active
- 2012-12-05 JP JP2015545618A patent/JP6174710B2/ja active Active
- 2012-12-05 WO PCT/CN2012/001629 patent/WO2014085947A1/zh not_active Ceased
- 2012-12-05 EP EP12889511.7A patent/EP2930189B1/en active Active
-
2017
- 2017-07-25 US US15/658,929 patent/US10336801B2/en active Active
-
2019
- 2019-05-17 US US16/415,143 patent/US20190270788A1/en not_active Abandoned
-
2023
- 2023-03-17 US US18/122,768 patent/US20230265150A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016503434A5 (enExample) | ||
| JP2019033754A5 (enExample) | ||
| JP2012095652A5 (enExample) | ||
| JP2015212284A5 (enExample) | ||
| JP2017514522A5 (enExample) | ||
| JP2010519931A5 (enExample) | ||
| RU2017134456A (ru) | Рекомбинантные связывающие белки и их применение | |
| EP4389898A3 (en) | T cell receptors | |
| JP2021505201A5 (enExample) | ||
| JP2015525217A5 (enExample) | ||
| JP2015532654A5 (enExample) | ||
| MX389173B (es) | Receptores de celulas t. | |
| JP2013513377A5 (enExample) | ||
| CA3062698A1 (en) | Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof | |
| JP2016527891A5 (enExample) | ||
| JP2010529860A5 (enExample) | ||
| JP2018138049A5 (enExample) | ||
| JP2015096070A5 (enExample) | ||
| JP2014515602A5 (enExample) | ||
| AU2017248122A1 (en) | T cell receptors | |
| JP2013541335A5 (enExample) | ||
| JP2013530689A5 (enExample) | ||
| JP2014525735A5 (enExample) | ||
| JP2017538401A5 (enExample) | ||
| JP2009527226A5 (enExample) |